No Reward-Like ICSS Effect Did Not Establish That a Synthetic Cannabinoid Lacks Abuse Risk

The synthetic cannabinoid CP55,940 did not facilitate intracranial self-stimulation in a mouse experiment. That is a negative finding in one reward-related assay, rather than proof that cannabinoid exposure cannot be reinforcing or problematic.

What the animals were doing

Male mice responded for electrical stimulation of a brain pathway. Investigators measured how acute and repeated CP55,940 changed responding across stimulation frequencies. CP55,940 is an experimental high-efficacy CB1 agonist, not THC or a cannabis product.

Suppression was the observed response

CP55,940 reduced responding, and rimonabant blocked that effect, supporting CB1 involvement. Repeated dosing produced rapid but incomplete tolerance to the suppression. It did not uncover a consistent increase in responding of the kind interpreted as reward-like facilitation in this procedure.

The withdrawal result was also assay-specific

After repeated dosing, neither discontinuation nor rimonabant challenge changed the ICSS measure as assessed. That does not exclude withdrawal signs that this procedure did not measure. Similarly, a null facilitation result cannot settle conditioned preference, drug self-administration or all features of human addiction.

Why this matters for cannabis interpretation

Different tests can capture different aspects of motivation and performance. A drug can suppress responding for reasons that are not identical to the absence of reinforcing properties. The experiment’s male-only sample, dose regimen and behavioral task limit generalization. It supports a precise statement about CP55,940 under these conditions, not a broad claim that THC, synthetic cannabinoids or repeated cannabis use have no abuse-related effects.

Related analysis: Similar Temperature Tolerance Did Not Make THC and JWH Cannabinoids Interchangeable.

Primary research

Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice. Drug and alcohol dependence (2015). DOI: 10.1016/j.drugalcdep.2015.01.022.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Low Saliva Volume Changed the Dilution of Cannabis Test Samples

A saliva specimen can contain THC and still have a collection problem that affects its reported concentration. In a controlled cannabis-smoking study, many early oral-fluid samples contained less saliva than the collection device intended. THC was nevertheless identified in every low-volume specimen collected after smoking. Detection did not make the…

Spread the love

Read Article: Low Saliva Volume Changed the Dilution of Cannabis Test Samples

Saliva Cannabis Detection Windows Change With THC AND Versus OR a Metabolite

Requiring both THC and its metabolite to exceed a cutoff can produce a different saliva detection window from accepting either compound. A controlled human cannabis-smoking study demonstrated that difference, particularly among occasional smokers. The result concerns how a test defines a positive sample; it does not establish how long a…

Spread the love

Read Article: Saliva Cannabis Detection Windows Change With THC AND Versus OR a Metabolite

A CB2 Knockout Experiment Did Not Test Whether Cannabis Causes Psychosis

A mouse experiment linked altered cannabinoid CB2 receptor function with methamphetamine-related behavioral responses. It did not administer cannabis or determine whether THC exposure caused a psychiatric disorder. The intervention was genetic receptor disruption Researchers studied mice with partial Cnr2 gene deletion and animals with deletion in a selected neuronal population….

Spread the love

Read Article: A CB2 Knockout Experiment Did Not Test Whether Cannabis Causes Psychosis

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us